Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.

Appropriate sensing of ventricular tachycardia (VT) and ventricular fibrillation (VF) is of paramount importance for safety of patients with implanted cardioverter defibrillators ICDs). Recently, the GuardianR ATP 4210. a new third generation ICD that uses programmable but fixed sensing during sinus...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 16; no. 5; pp. 1070 - 1080
Autores principales: Singer I, Adams L, Austin E
Formato: Journal Article
Publicado: Wiley-Blackwell May1993
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106037470&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106037470
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: May1993
      vid: 16
      iid: 5
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106037470
        2009412691
        NLM7685888
        106037470
      ppf: 1070
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.
      aug:
        au:
          Singer I
          Adams L
          Austin E
      sug:
      ab: Appropriate sensing of ventricular tachycardia (VT) and ventricular fibrillation (VF) is of paramount importance for safety of patients with implanted cardioverter defibrillators ICDs). Recently, the GuardianR ATP 4210. a new third generation ICD that uses programmable but fixed sensing during sinus rhythm and doubles its sensitivity settings when VF is detected, to a maximum programmable sensitivity of 1 mV, has been tested in phase I and II clinical trials. A reconfirmation algorithm of this ICD confirms the presence of VT or VF prior to therapy. This case report describes undersensing of VF in a patient with the GuardianR ATP 4210 at the maximum programmed sensitivity of 1 mV. Inappropriate episodes of asystole and prolonged bradycardias were also observed in this patient due to shortcomings in the reconfirmation algorithm design. Reoperation was required, with positioning of a new endocardial sensing lead to correct the undersensing of VF. This, however, did not correct asystolic pauses following antitachycardia pacing or spontaneous tachycardio termination prior to therapy. This case report highlights the hazards of fixed gain sensing for implantable ICDs and a potential limitation of a specific tachyarrhythmia reconfirmation algorithm used in this device.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N